Recent years have witnessed groundbreaking advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://brendaueoy334882.blogkoo.com/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide-58313656